2
Oct 27 (Reuters) – Rapport Therapeutics, Inc.: * RAPPORT THERAPEUTICS OFFERS CONVERTIBLE SENIOR NOTES DUE 2032; SIZE NOT DISCLOSED- SEC FILING Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
